Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1800133	HSK16149	crisugabalin besylate	Injection	Chemical Drugs(1)	New Drug Application	2018-08-29	四川海思科制药有限公司	Sichuan Haisco Pharmaceutical Co Ltd	In Review	2018-08-27	view
CXHB1900045	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs	Supplementary Application	2019-09-05	四川海思科制药有限公司	Sichuan Haisco Pharmaceutical Co Ltd	Certificate Issued	2019-11-05	view
CXHL2400046	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs(1)	New Drug Application	2024-01-10		Haisco Pharmaceutical Group Co Ltd			view
CXHS2300081	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs(1)	New Drug Application	2023-09-13					view
CXHB1900044	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs	Supplementary Application	2019-09-05	四川海思科制药有限公司	Sichuan Haisco Pharmaceutical Co Ltd	Certificate Issued	2019-11-05	view
CXHL2101158	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs(1)	New Drug Application	2021-05-27		Sichuan Haisco Pharmaceutical Co Ltd			view
CXHL1800135	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs(1)	New Drug Application	2018-08-29	四川海思科制药有限公司	Sichuan Haisco Pharmaceutical Co Ltd	In Review	2018-08-27	view
CXHS2200058	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs(1)	New Drug Application	2022-10-27					view
CXHL1800134	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs(1)	New Drug Application	2018-08-29	四川海思科制药有限公司	Sichuan Haisco Pharmaceutical Co Ltd	In Review	2018-08-27	view
CXHL2400122	HSK16149胶囊	crisugabalin besylate	Capsule	Chemical Drugs(1)	New Drug Application	2024-01-30		Haisco Pharmaceutical Group Co Ltd			view